Event Abstract Back to Event MMN as an index of premorbid function in schizophrenia Daniel C. Javitt1*, G. Bar2 and M. Weiser2 1 Nathan Kline Institute for Psychiatric Research,New York University School of Medicine, United States 2 Sheba Medical Center, Tel Hashomer, Israel Mismatch negativity (MMN) is among the best established neurophysiological markers of neurocognitive dysfunction in schizophrenia. MMN abnormalities are reproduced by antagonists of N-methyl-D-aspartate (NMDA)-type glutamate receptors. As such, MMN may serve as an index of impaired glutamatergic function in schizophrenia. To date, literature regarding MMN utility as an endophenotype have been conflicting, with some studies showing deficits in family members of schizophrenia probands and in individuals at high symptomatic risk for schizophrenia but other studies showing normal MMN at illness onset and in unaffected family members. Umbricht et al. (Biol Psychiatry, 59:762, 2006) did not find deficits in first-episode patients as a group, but significant reduction in MMN in first episode subjects with poor premorbid function as indexed by premorbid educational achievement. The present study provides further evaluation of the relationship between premorbid function and MMN generation in a group of 31 chronic patients with good (n=19) vs. poor premorbid (n=12) patients vs. controls (n=20) assessed using the premorbid adjustment scale. Patients were assessed on auditory MMN to pitch and duration deviants, and on visual P1 to low contrast stimuli. As predicted, patients with poor premorbid function showed significant reductions in MMN to pitch deviants relative to controls, whereas good premorbids did not. Neither group showed a significant deficit in duration MMN generation. Furthermore, deficits in MMN generation to pitch deviants correlated significantly with impaired general premorbid function. By contrast to MMN findings, both good and poor premorbid patients showed reduced visual P1 generation. These findings support the concept that MMN may, at least in part, index a subgroup of schizophrenia individuals with poor premorbid function even during chronic illness phases, whereas visual P1 deficits may index more general aspects of the schizophrenia diathesis. Poor premorbid patients, in general, show worse outcome and may therefore be overrepresented in patient samples drawn from chronic care settings. Furthermore, such patients correspond most closely to the NMDA dysfunction phenotype, and may therefore be enriched in patients with NMDA dysfunction as a core pathological feature of their illness. Rather than serving as a general endophenotype, MMN may serve as an endophenotype for poor premorbid patients. Family studies differentiating probands by premorbid functional level are required. Conference: MMN 09 Fifth Conference on Mismatch Negativity (MMN) and its Clinical and Scientific Applications, Budapest, Hungary, 4 Apr - 7 Apr, 2009. Presentation Type: Oral Presentation Topic: Symposium 1: MMN as a potential endophenotype in schizophrenia Citation: Javitt DC, Bar G and Weiser M (2009). MMN as an index of premorbid function in schizophrenia. Conference Abstract: MMN 09 Fifth Conference on Mismatch Negativity (MMN) and its Clinical and Scientific Applications. doi: 10.3389/conf.neuro.09.2009.05.034 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 20 Mar 2009; Published Online: 20 Mar 2009. * Correspondence: Daniel C Javitt, Nathan Kline Institute for Psychiatric Research,New York University School of Medicine, New York, United States, javitt@nki.rfmh.org Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Daniel C Javitt G. Bar M. Weiser Google Daniel C Javitt G. Bar M. Weiser Google Scholar Daniel C Javitt G. Bar M. Weiser PubMed Daniel C Javitt G. Bar M. Weiser Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.
Read full abstract